OLMA (Olema Pharmaceuticals) Retained Earnings: $-650.65 Mil (As of Mar. 2026)


OLMA Olema Pharmaceuticals inc OLMA
28 GF Score
Price $12.48
! 2 Warning Signs
View Full Analysis

What is Olema Pharmaceuticals Retained Earnings?

Olema Pharmaceuticals OLMA -2.19% 28 Retained Earnings is $-650.65 Mil as of Mar. 2026. GuruFocus rates OLMA with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Olema Pharmaceuticals's retained earnings for the quarter that ended in Mar. 2026 was $-650.65 Mil.

Olema Pharmaceuticals's quarterly retained earnings declined from Sep. 2025 ($-551.50 Mil) to Dec. 2025 ($-597.56 Mil) and declined from Dec. 2025 ($-597.56 Mil) to Mar. 2026 ($-650.65 Mil).

Olema Pharmaceuticals's annual retained earnings declined from Dec. 2023 ($-305.63 Mil) to Dec. 2024 ($-435.11 Mil) and declined from Dec. 2024 ($-435.11 Mil) to Dec. 2025 ($-597.56 Mil).


Olema Pharmaceuticals  (NAS:OLMA) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Olema Pharmaceuticals Retained Earnings Historical Data

* Premium members only.

The historical data trend for Olema Pharmaceuticals's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olema Pharmaceuticals Retained Earnings Chart

Olema Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial -104.19 -208.98 -305.63 -435.11 -597.56

Olema Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -465.50 -509.28 -551.50 -597.56 -650.65
OLMA
28GF Score
Olema Pharmaceuticals inc OLMA
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Olema Pharmaceuticals Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-650.65 Mil mean?
Olema Pharmaceuticals (OLMA) has a Retained Earnings of $-650.65 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Olema Pharmaceuticals and its competitors.
Is Olema Pharmaceuticals' Retained Earnings too high?
Olema Pharmaceuticals' current Retained Earnings is $-650.65 Mil. Overall, Olema Pharmaceuticals has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Olema Pharmaceuticals' Retained Earnings compare to DRTS and ORIC?
Olema Pharmaceuticals' Retained Earnings of $-650.65 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Olema Pharmaceuticals and its competitors. Olema Pharmaceuticals's current Retained Earnings is $-650.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olema Pharmaceuticals stock overvalued right now?
Olema Pharmaceuticals (OLMA) has a current Retained Earnings of $-650.65 Mil. The current Retained Earnings is $-650.65 Mil. Olema Pharmaceuticals' overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Olema Pharmaceuticals (OLMA), the current Retained Earnings is $-650.65 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Olema Pharmaceuticals Business Description

Address 780 Brannan Street, San Francisco, CA, USA, 94103
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
28GF Score

Get the complete analysis for OLMA

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.48
Price